Phosphorylated tau in neuritic plaques of APP^sw/Tau^vlw transgenic mice and Alzheimer disease

By Pérez Mar   Morán María   Ferrer Isidre   Ávila Jesús   Gómez-Ramos Pilar  

Acta Neuropathologica, Vol. 116, Iss. 4, 2008-10 ,pp. : 409-418

Springer Publishing Company

Access to resources Recommend Favorite

Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer’s disease

By Zurbriggen Rinaldo   Amacker Mario   Kammer Andreas   Westerfeld Nicole   Borghgraef Peter   Leuven Fred   Auwera Ingrid   Wera Stefaan  

Journal of Molecular Neuroscience, Vol. 27, Iss. 2, 2005-10 ,pp. : 157-166

Humana Press, Inc

Access to resources Recommend Favorite

A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and -amyloid plaques in a mouse model of Alzheimer's disease

By Zhang J.   Wu X.   Qin C.   Qi J.   Ma S.   Zhang H.   Kong Q.   Chen D.   Ba D.   He W.  

Neurobiology of Disease, Vol. 14, Iss. 3, 2003-12 ,pp. : 365-379

Elsevier

Access to resources Recommend Favorite

Amyloid-β Decreases Nitric Oxide Production in Cultured Retinal Neurons: A Possible Mechanism for Synaptic Dysfunction in Alzheimer’s Disease?

By Oliveira Leandro   Louzada Paulo   Mello Fernando   Ferreira Sérgio  

Neurochemical Research, Vol. 36, Iss. 1, 2011-01 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite

Apolipoprotein E dose-dependent modulation of β-amyloid deposition in a transgenic mouse model of Alzheimer’s disease

By DeMattos Ronald  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 255-262

Humana Press, Inc

Access to resources Recommend Favorite